Efficacy of greater occipital nerve block in postdural puncture headache

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200621047860N1

Enrollment

Registered

2020-08-06

Start date

2019-04-04

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache. Other headache syndromes

Interventions

Intervention 1: Intervention group: A single bilateral greater occipital nerve block using 2% lidocaine, 2cc for each side and normal saline, 2.5cc for each side. Intervention 2: Control group: Conser

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Paitents with post dural puncture headache based on IHS criteria

Exclusion criteria

Exclusion criteria: history of greater occipital nerve injection within previous three months hypersensitivity to the Lidocaine or Triamcinolone seizure local infection of the scalp medication overuse headache head surgery Severe hepatic failure unstable vital sings fever chronic daily headache thunderclap headache after dural puncture

Design outcomes

Primary

Measure	Time frame
Headache. Timepoint: 10 min, 2h, 6h,12h, 24h, 48h after injection. Method of measurement: Visual analog scale questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSiamak Abdi Dizaji

Tehran University of Medical Sciences

siamak.abdi@yahoo.com+98 21 8802 7412

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026